Amgen Inc on Wednesday said third-quarter adjusted profit rose 17% due to stronger sales of drugs such as osteoporosis treatment Prolia and psoriasis medication Otezla, bucking challenges from lower ...
India-based Biocon’s biosimilars subsidiary has reached a settlement and license agreement with Amgen that clears the path ...
remove-circle Internet Archive's in-browser bookreader "theater" requires JavaScript to be enabled. It appears your browser does not have it turned on. Please see ...
Enoby and Xtrenbo are FDA-approved biosimilars for denosumab, providing cost-effective alternatives to Prolia and Xgeva for ...
Denosumab is indicated for treating osteoporosis in postmenopausal women, preventing skeletal-related complications in cancer that has spread to the bone.
In an email to ICE, the head of the Florida Police Chiefs' Association said it was "incredibly disappointing" that the agency was poaching officers despite local law enforcement committing resources ...
Findings showed denosumab-kyqq demonstrated similar quality, safety, and efficacy to the reference product. Bosaya is approved to treat postmenopausal women with osteoporosis at high risk for fracture ...
MENTOR, Ohio — Residents will have a chance to help shape Mentor’s future development at a public meeting on the city’s 2025 Comprehensive Land Use Plan update. The meeting is scheduled for Oct. 1 ...
Hyderabad: Dr Reddy's Laboratories Ltd., has announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending ...
Hyderabad, Sep 23: Pharmaceutical major Aurobindo Pharma is set to enter the global market for osteoporosis and cancer-related bone treatments with its biosimilar version of Denosumab, following ...
Shanghai Henlius Biotech, Inc., and Organon announced the European Commission (EC) has granted marketing authorization for Bildyos (denosumab) injection 60 mg/mL and Bilprevda (denosumab) injection ...
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the European Medicines Agency’s ...